Literature DB >> 23210573

Detection and clinical significance of gene rearrangements in Chinese patients with adult acute lymphoblastic leukemia.

Fang Liu1, Li Gao, Yu Jing, Yuan-Yuan Xu, Yi Ding, Min-Hang Zhou, Chao Ma, Mian-Yang Li, Jun-Zhong Sun, Li-Li Wang, Li Yu.   

Abstract

This study aimed to develop a novel multiplex reverse transcription-nested polymerase chain reaction (RT-nPCR) assay to accurately and effectively detect 10 common gene rearrangements in adult acute lymphoblastic leukemia (ALL) and to examine the clinicopathologic characteristics and other genetic aberrations of patients with ALL expressing different fusion genes. Our RT-nPCR assay had a positive detection rate of 35.15% (90/256) for the 10 fusion genes. BCR-ABL1, FUS-ERG, MLL-AF4, ETV6-RUNX1, E2A-PBX1, dupMLL, MLL-AF10, MLL-ENL, SET-NUP214 and SIL-TAL1 were detected in 36 (14.06%), 14 (5.47%), 14 (5.47%), four (1.56%), four (1.56%), five (1.95%), four (1.56%), two (0.78%), two (0.78%) and five patients (1.95%), respectively. The RT-nPCR results were further confirmed by split-out PCR, and cytogenetic and fluorescence in situ hybridization (FISH) analysis revealed corresponding translocations and fusions in 63 and 74 cases, respectively. JAK2 and IKZF1 mutations were commonly detected in patients with BCR-ABL1 ALL, and HOX overexpression was highly correlated with MLL fusions and SET-NUP214. This study demonstrates that RT-nPCR is an effective method for identifying 10 gene rearrangements in adult ALL, and it could potentially be developed for diagnostic use and prognostic studies of ALL.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23210573     DOI: 10.3109/10428194.2012.754888

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  11 in total

1.  A case of pediatric ALL with t(16;21)(p11.2;q22) and FUS-ERG rearrangement.

Authors:  Mariela C Coccé; Cristina N Alonso; Jorge Rossi; Maria S Felice; Myriam R Gitter; Marta S Gallego
Journal:  Blood Res       Date:  2015-03-24

2.  Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells.

Authors:  Jinbo Fang; Huali Xu; Chunshu Yang; Sharif Morsalin; Shubhalaxmi Kayarthodi; Kunchala Rungsrisuriyachai; Ujwala Gunnal; Brittany Mckenzie; Veena N Rao; E Shyam P Reddy
Journal:  J Pharm Sci Pharmacol       Date:  2014-09-01

3.  Molecular Mechanism of Activation of Transforming Growth Factor Beta/Smads Signaling Pathway in Ets Related Gene-Positive Prostate Cancers.

Authors:  Jinbo Fang; Huali Xu; Chunshu Yang; Shubha Kayarthodi; Roland Matthews; Veena N Rao; E Shyam P Reddy
Journal:  J Pharm Sci Pharmacol       Date:  2014-03

4.  [Analysis of the clinical characteristics of 24 cases of hematological malignancies with SET-NUP214 fusion gene].

Authors:  S M Chen; W J Song; Y Z Qin; Z Wang; H Dang; Y Shi; Q He; Q Jiang; H Jiang; X J Huang; Y Y Lai
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-06-14

5.  B-cell acute lymphoblastic leukemia associated with SET-NUP214 rearrangement: A case report and review of the literature.

Authors:  Hong-Hu Zhu; Xiao-Su Zhao; Ya-Zhen Qin; Yue-Yun Lai; Hao Jiang
Journal:  Oncol Lett       Date:  2016-02-23       Impact factor: 2.967

6.  NUP214 fusion genes in acute leukemia (Review).

Authors:  Min-Hang Zhou; Qing-Ming Yang
Journal:  Oncol Lett       Date:  2014-06-18       Impact factor: 2.967

7.  [Clinical characteristics of four SET-NUP214 positive acute leukemia patients].

Authors:  X Y Dong; Y L Li; L S Liu; W Cheng; B J Shang; L Zhang; M Y Shi; F Wang; K Sun
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-12-14

8.  CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.

Authors:  Mianyang Li; Li Gao; Zhenling Li; Junzhong Sun; Hui Zhang; Haoqing Duan; Yigai Ma; Chengbin Wang
Journal:  Oncotarget       Date:  2016-05-24

9.  RASSF1A hypermethylation is associated with ASXL1 mutation and indicates an adverse outcome in non-M3 acute myeloid leukemia.

Authors:  Fang Liu; Ming Gong; Li Gao; Xiaoping Cai; Hui Zhang; Yigai Ma
Journal:  Onco Targets Ther       Date:  2017-08-22       Impact factor: 4.147

Review 10.  NUP214 in Leukemia: It's More than Transport.

Authors:  Adélia Mendes; Birthe Fahrenkrog
Journal:  Cells       Date:  2019-01-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.